Skip to content

Mindfulness in child and adolescent psychiatry

Mindfulness in child and adolescent psychiatry - Mindfulness in child and adolescent psychiatry

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON38850
Enrollment
625
Registered
2013-06-20
Start date
2013-07-01
Completion date
Unknown
Last updated
2024-04-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Attention Deficit Hyperactivity Disorder + Autism Spectrum Disorder Attention Deficit Hyperactivity Disorder (ADHD) + Autism Spectrum Disorder (ASD)

Interventions

Subjects from study population 1, 2, 3 and 4 receive MFT that consists of 8 weekly 1.5 hour group sessions. During the MFT of study population 1, 2, 3 and 4, parents receive 8 weeks parallel MPT (pM

Sponsors

Universiteit van Amsterdam
Lead Sponsor

Eligibility

Age
2 Years to 99 Years

Inclusion criteria

Inclusion criteria: In order to be eligible to participate in this study, a subject must meet all of the following criteria:;For study populations 1 and 2: Inclusion criteria for the ADHD group are (1) a DSM-IV diagnosis of ADHD established with the parent and child version of the Anxiety Disorders Interview Schedule for Children (ADIS-C), (2) an estimated IQ of 80 or higher, (3) participants have to be able to attend the first session, with a minimum of at least 6 out of 8 sessions, and (4), at least one parent has to be able to attend the parent sessions and (5), participants have to be between 9 and 12 years old (elementary school) for the children group and between 12 and 18 years old (secondary school) for the adolescent group. ;For study population 3 and 4: Inclusion criteria for the ASD group are (1) a DSM-IV diagnosis of ASD confirmed by the Autism Diagnostic Observation Schedule - Generic (ADOS-G), (2) an estimated IQ of 80 or higher, (3) participants have to be able to attend the first session, with a minimum of at least 6 out of 8 sessions, and (4), at least one parent has to be able to attend the parent sessions, and (5), participants have to be between 9 and 12 years old (elementary school) for the children group and between 12 and 23 years old (secondary school and beyond) for the adolescent group.;For study population 5: Inclusion criteria for the MPT are (1) the experience of childrearing stress, (2) either a DSM-IV diagnosis of the parent or the child, (3) an estimated IQ of 80 or higher, and (4), participants have to be able to attend the first session, with a minimum of at least 6 out of 8 sessions.

Exclusion criteria

Exclusion criteria: A potential subject who meets any of the following criteria will be excluded from participation in this study:;For study populations 1 and 2: Participants are excluded from participation when (1) inadequate mastery of the Dutch language by the child or parents, (2) severe behavioral problems established by a CD on the ADIS-C, (3) comorbid developmental disorder (autistic), and (4), participating in another ongoing psychological intervention (apart from *stable* medication). ;For study population 3 and 4: Participants are excluded from participation when (1) inadequate mastery of the Dutch language by the child or parents, (2) severe behavioral problems established by the ADIS-C, (3) presence of suicidal risk, (4) presence of non-treated psychotic disorders, and (5), participating in another ongoing psychological intervention (apart from *stable* medication). ;For study population 5: Participants are excluded from participation when (1) inadequate mastery of the Dutch language and (2), participating in another ongoing psychological intervention (apart from *stable* medication).

Design outcomes

Primary

MeasureTime frame
Primary outcome measure for study populations 1, 2, 3, 4 and 5 is attention problems.

Secondary

MeasureTime frame
Secondary outcome measures are anxiety and depression symptoms, stress, fatigue, quality of life, family emotion regulation, and mindfulness for study population 1, 2, 3, 4 and 5. Population specific outcome measures are hyperactivity and impulsivity in study populations 1 and 2; rumination and problems in social interaction and communication in study population 3 and 4; and self-compassion, acceptence and experiential avoidance in study population 5.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)